Biolase Stock Net Income
BIOLDelisted Stock | USD 0.05 0.02 27.46% |
BIOLASE fundamentals help investors to digest information that contributes to BIOLASE's financial success or failures. It also enables traders to predict the movement of BIOLASE Stock. The fundamental analysis module provides a way to measure BIOLASE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIOLASE stock.
BIOLASE |
BIOLASE Company Net Income Analysis
BIOLASE's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current BIOLASE Net Income | (20.63 M) |
Most of BIOLASE's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIOLASE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, BIOLASE reported net income of (20.63 Million). This is 106.05% lower than that of the Health Care Equipment & Supplies sector and 108.66% lower than that of the Health Care industry. The net income for all United States stocks is 103.61% higher than that of the company.
BIOLASE Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIOLASE's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIOLASE could also be used in its relative valuation, which is a method of valuing BIOLASE by comparing valuation metrics of similar companies.BIOLASE is currently under evaluation in net income category among its peers.
BIOLASE Fundamentals
Return On Equity | -5.05 | |||
Return On Asset | -0.27 | |||
Profit Margin | (0.44) % | |||
Operating Margin | (0.45) % | |||
Current Valuation | 13.65 M | |||
Shares Outstanding | 33.4 M | |||
Shares Owned By Insiders | 0.32 % | |||
Shares Owned By Institutions | 8.97 % | |||
Number Of Shares Shorted | 2.1 M | |||
Price To Earning | (7.23) X | |||
Price To Book | 0.77 X | |||
Price To Sales | 0.1 X | |||
Revenue | 49.16 M | |||
Gross Profit | 16.53 M | |||
EBITDA | (15.14 M) | |||
Net Income | (20.63 M) | |||
Cash And Equivalents | 9.96 M | |||
Cash Per Share | 1.39 X | |||
Total Debt | 17.91 M | |||
Debt To Equity | 1.07 % | |||
Current Ratio | 2.46 X | |||
Book Value Per Share | (0.06) X | |||
Cash Flow From Operations | (14.09 M) | |||
Short Ratio | 1.09 X | |||
Earnings Per Share | (11.97) X | |||
Price To Earnings To Growth | (0.22) X | |||
Target Price | 1.95 | |||
Number Of Employees | 157 | |||
Beta | 0.75 | |||
Market Capitalization | 4.31 M | |||
Total Asset | 35.1 M | |||
Retained Earnings | (316.8 M) | |||
Working Capital | 5.2 M | |||
Current Asset | 34.8 M | |||
Current Liabilities | 15.11 M | |||
Net Asset | 35.1 M |
About BIOLASE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIOLASE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIOLASE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIOLASE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in BIOLASE Stock
If you are still planning to invest in BIOLASE check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BIOLASE's history and understand the potential risks before investing.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |